Product Code: ETC8846706 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
NGS is revolutionizing cancer diagnostics in the Philippines by enabling early detection and personalized treatment strategies. The ability to analyze genetic mutations and identify targeted therapies is improving patient outcomes. Government initiatives supporting cancer research and collaborations with international healthcare organizations are further propelling market growth. However, the high cost of NGS-based diagnostics and limited access to advanced sequencing technologies in rural areas remain significant hurdles.
The rising incidence of cancer and the need for early and precise diagnostics are driving the next-generation sequencing (NGS) market in cancer diagnostics in the Philippines. NGS-based tests enable comprehensive tumor profiling, leading to personalized treatment strategies. Additionally, increasing investments in oncology research and government programs promoting cancer screening are supporting market growth.
The next-generation sequencing market for cancer diagnostics faces challenges related to affordability, regulatory approvals, and integration with traditional diagnostic methods. Advanced genomic testing for cancer is expensive, making it difficult for many healthcare providers and patients to afford. Regulatory hurdles also delay the approval of NGS-based cancer tests. Additionally, integrating NGS with conventional diagnostic techniques requires significant investment and training.
The application of next-generation sequencing in cancer diagnostics is opening new investment avenues in the Philippines. The rising incidence of cancer and the need for early detection and personalized treatments are driving demand for NGS-based diagnostic solutions. Investments in liquid biopsy, AI-driven genomic analysis, and precision oncology are expected to shape the future of cancer diagnostics in the country.
The NGS in cancer diagnostic market in the Philippines is being shaped by government initiatives promoting precision oncology. Policies supporting genetic testing for early cancer detection and treatment personalization are driving the adoption of NGS in healthcare settings. Funding for national cancer screening programs and partnerships with biotechnology firms are expanding access to cutting-edge genomic diagnostics. Regulatory frameworks ensuring the quality and affordability of NGS-based cancer diagnostics are also strengthening the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Industry Life Cycle |
3.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Porter's Five Forces |
3.5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Product and Service, 2021 & 2031F |
3.7 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.8 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Trends |
6 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Types |
6.1 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Lung, 2021- 2031F |
6.1.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Breast, 2021- 2031F |
6.1.5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Colorectal, 2021- 2031F |
6.1.6 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Prostrate, 2021- 2031F |
6.1.7 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Stomach, 2021- 2031F |
6.1.8 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Cervical, 2021- 2031F |
6.1.9 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Product and Service |
6.2.1 Overview and Analysis |
6.2.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Kits, 2021- 2031F |
6.2.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.2.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Technologies |
6.3.1 Overview and Analysis |
6.3.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Panels/Targeted Sequencing and Resequencing, 2021- 2031F |
6.3.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.3.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.3.5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By RNA Sequencing, 2021- 2031F |
6.3.6 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F |
6.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By NGS Sequencing, 2021- 2031F |
6.4.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.4.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By NGS Pre-Sequencing, 2021- 2031F |
6.5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Screening, 2021- 2031F |
6.5.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.5.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Pathology Labs, 2021- 2031F |
6.6.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Oncology Centers, 2021- 2031F |
6.6.5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Import-Export Trade Statistics |
7.1 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Export to Major Countries |
7.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Imports from Major Countries |
8 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Performance Indicators |
9 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Opportunity Assessment |
9.1 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Product and Service, 2021 & 2031F |
9.3 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Technologies, 2021 & 2031F |
9.4 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Competitive Landscape |
10.1 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Philippines Next Generation Sequencing (NGS) in Cancer Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |